The aspiration saga during primary PCI for STEMI: yes or no or sometimes?

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Biology

Background:

• Acute ST-elevation myocardial infarction (STEMI) requires rapid reperfusion to prevent heart muscle damage.
• Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
• Microvascular obstruction (MVO) after PCI can impede reperfusion and worsen outcomes.

Purpose of the Study:

• To review the current evidence on aspiration thrombectomy in STEMI patients undergoing primary PCI.
• To evaluate the effectiveness of aspiration thrombectomy in reducing distal embolization and MVO.
• To discuss the current role and future implications of aspiration thrombectomy in clinical practice.

Main Methods:

• Review of existing clinical trials and observational studies on aspiration thrombectomy in STEMI.
• Analysis of data comparing outcomes in patients treated with and without aspiration thrombectomy.
• Discussion of the pathophysiology of MVO and its impact on STEMI treatment.

Main Results:

• Initial studies suggested a benefit of aspiration thrombectomy in STEMI.
• Large, multicenter randomized trials have failed to demonstrate improved clinical outcomes with routine aspiration thrombectomy.
• Aspiration thrombectomy did not significantly reduce rates of MVO or improve myocardial reperfusion.

Conclusions:

• Routine use of aspiration thrombectomy in STEMI patients undergoing primary PCI is not supported by current evidence.
• The strategy does not appear to improve clinical outcomes or reduce microvascular obstruction.
• Further research may identify specific patient subgroups who could benefit from this intervention.